Zibo Qianhui Biological Technology Co.,Ltd

Zibo Qianhui Biological Technology Co., Ltd (formerly Zibo Qianhui Fine Chemical Co., Ltd) is a Chinese company established in 2006. The firm has developed a GMP-compliant facility for pharmaceutical excipients and has progressed through a series of milestones in both licensing and certification. In 2010, the company constructed a GMP workshop dedicated to pharmaceutical excipients, underscoring its commitment to quality manufacturing. By 2011, it had obtained a drug manufacturing license, enabling its involvement in pharmaceutical production. In May 2012, the company secured a registration certificate of drug excipient for HPBCD, signifying regulatory approval for its excipient product. In 2014, the company achieved an accepted number from the China SFDA for sulfobutylether beta-cyclodextrin and submitted a Drug Master File (DMF) to the U.S. FDA, reflecting ongoing engagement with international regulatory processes. The organization earned ISO 9001:2015 certification in 2016, highlighting its adherence to established quality management standards. In addition to regulatory milestones, Zibo Qianhui Biological Technology Co., Ltd has contributed to the cyclodextrin field by sponsoring a Chinese cyclodextrin academic forum in 2016 and inviting industry experts to advise on development directions and share application experiences.